Table 3 Clinical characteristics, use of therapeutic procedures and hospital outcomes before and after propensity score matching in women patients hospitalized with hemorrhagic stroke according to the presence of type 2 diabetes
Variables | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
T2DM | No T2DM | p-value | T2DM | No T2DM | p-value | |
Nontraumatic subarachnoid hemorrhage, n (%) | 593 (13.26) | 5603 (27.33) | < 0.001 | 593 (13.26) | 607 (13.57) | 0.664 |
Nontraumatic intracerebral hemorrhage, n (%) | 2665 (59.58) | 10,914 (53.23) | < 0.001 | 2665 (59.58) | 2671 (59.71) | 0.897 |
Other and unspecified nontraumatic intracranial hemorrhage, n (%) | 1215 (27.16) | 3985 (19.44) | < 0.001 | 1215 (27.16) | 1195 (26.72) | 0.633 |
Age, mean (SD) | 78.39 (9.75) | 72.33 (14.74) | < 0.001 | 78.39 (9.75) | 79.18 (9.94) | < 0.001 |
CCI mean (SD) | 0.67 (0.83) | 0.46 (0.69) | < 0.001 | 0.67 (0.83) | 0.61 (0.79) | 0.001 |
Obesity, n (%) | 471 (10.53) | 894 (4.36) | < 0.001 | 471 (10.53) | 380 (8.5) | 0.001 |
Hypertension, n (%) | 3079 (68.84) | 10,026 (48.9) | < 0.001 | 3079 (68.84) | 3259 (72.86) | < 0.001 |
Lipid metabolism disorders, n (%) | 2147 (48) | 5219 (25.46) | < 0.001 | 2147 (48) | 2117 (47.33) | 0.525 |
Renal disease, n (%) | 575 (12.85) | 1032 (5.03) | < 0.001 | 575 (12.85) | 480 (10.73) | 0.002 |
Atrial fibrillation, n (%) | 1217 (27.21) | 3425 (16.71) | < 0.001 | 1217 (27.21) | 1189 (26.58) | 0.504 |
Congestive heart failure, n (%) | 322 (7.2) | 697 (3.4) | < 0.001 | 322 (7.2) | 276 (6.17) | 0.052 |
Peripheral vascular disease, n (%) | 96 (2.15) | 298 (1.45) | 0.001 | 96 (2.15) | 69 (1.54) | 0.034 |
Acute myocardial infarction, n (%) | 108 (2.41) | 212 (1.03) | < 0.001 | 108 (2.41) | 98 (2.19) | 0.481 |
Dementia, n (%) | 444 (9.93) | 1472 (7.18) | < 0.001 | 444 (9.93) | 427 (9.55) | 0.544 |
Anemia, n (%) | 205 (4.58) | 517 (2.52) | < 0.001 | 205 (4.58) | 143 (3.2) | 0.001 |
Alcohol abuse, n (%) | 38 (0.85) | 365 (1.78) | < 0.001 | 38 (0.85) | 41 (0.92) | 0.735 |
Depression, n (%) | 367 (8.2) | 1550 (7.56) | 0.142 | 367 (8.2) | 314 (7.02) | 0.035 |
Sepsis, n (%) | 50 (1.12) | 204 (1) | 0.458 | 50 (1.12) | 27 (0.6) | 0.008 |
Use of oral anticoagulants,, n (%) | 915 (20.46) | 2517 (12.28) | < 0.001 | 915 (20.46) | 850 (19.00) | 0.084 |
Use of antiplatelet agents, n (%) | 598 (13.37) | 1369 (6.68) | < 0.001 | 598 (13.37) | 543 (12.14) | 0.081 |
Mechanical ventilation, n (%) | 426 (9.52) | 2729 (13.31) | < 0.001 | 426 (9.52) | 440 (9.84) | 0.617 |
Decompressive craniectomy, n (%) | 149 (3.33) | 1064 (5.19) | < 0.001 | 149 (3.33) | 190 (4.25) | 0.023 |
LOHS, median (IQR) | 7 (11) | 8 (13) | < 0.001 | 7 (11) | 7 (11) | 0.848 |
In-hospital mortality, n (%) | 1471 (32.89) | 5830 (28.44) | < 0.001 | 1471 (32.89) | 1379 (30.83) | 0.037 |